GSK hires Rapp for global NiQuitin CQ and Alli accounts
by Matt Williams, 11 June 2009, 06:30am
LONDON - GlaxoSmithKline, the healthcare giant, has handed Rapp the global direct marketing and digital accounts for its NiQuitin CQ and Alli brands after a pitch against LBi, Razorfish and EHS Brann.
To view this content you need to sign in or register for free.



